Aspire Private Capital »

Redhill Biopharma shares owned by Aspire Private Capital

Quarter-by-quarter ownership of Redhill Biopharma (RDHL) shares owned by Aspire Private Capital from 13F filings

Historical chart of Aspire Private Capital investment in Redhill Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Redhill Biopharma held by Aspire Private Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Redhill Biopharma by Aspire Private Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $215 406 0.53
2023-12-31 $591 405 1.46

More positions owned by Aspire Private Capital

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ssga Active Tr Spdr Ssga Fxd (FISR)
Vanguard Index Fds Growth Etf (VUG)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Vanguard Index Fds Value Etf (VTV)
Vanguard Mun Bd Fds Tax Exempt Bd (VTEB)
Ssga Active Tr Spdr Ssga Us Sct (XLSR)
Spdr Ser Tr Portfolio Agrgte (SPAB)
Vanguard Charlotte Fds Total Int Bd Etf (BNDX)
Spdr Index Shs Fds Portfolio Emg Mk (SPEM)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Spdr Ser Tr Bloomberg High Y (JNK)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Spdr Ser Tr Portfolio S&p600 (SPSM)

View all positions for Aspire Private Capital

Top funds holding Redhill Biopharma

Gagnon Securities
Federation des caisses Desjardins du Quebec
UBS Group
Rhumbline Advisers
We Are One Seven
Two Sigma Securities
Group One Trading
Morgan Stanley
Aspire Private Capital
Royal Bank of Canada
Bank of America Corporation
Advisor Group Holdings
Wells Fargo & Company
Jpmorgan Chase & Co
IFP Advisors

View all funds holding Redhill Biopharma